PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Brain Ischemia D002545 89 associated lipids
Seizures D012640 87 associated lipids
Arteriosclerosis D001161 86 associated lipids
Atherosclerosis D050197 85 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Alzheimer Disease D000544 76 associated lipids
Stomach Ulcer D013276 75 associated lipids
Leukemia D007938 74 associated lipids
Hyperlipidemias D006949 73 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Coronary Disease D003327 70 associated lipids
Colitis D003092 69 associated lipids
Melanoma D008545 69 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Neuroblastoma D009447 66 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Reperfusion Injury D015427 65 associated lipids
Pain D010146 64 associated lipids
Weight Loss D015431 56 associated lipids
Nerve Degeneration D009410 53 associated lipids
Parkinson Disease D010300 53 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Asthma D001249 52 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Osteosarcoma D012516 50 associated lipids
Thrombosis D013927 49 associated lipids
Precancerous Conditions D011230 48 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Leukemia P388 D007941 43 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arthritis D001168 41 associated lipids
Hypotension D007022 41 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Inoué S [Sleep substances: their roles and evolution]. 1983 Seikagaku pmid:6355327
Tasaka K et al. Prostaglandin D2 induces release of luteinizing hormone from the rat pituitary gland without the modulation of hypothalamic luteinizing hormone releasing hormone. 1983 J. Endocrinol. pmid:6361197
Horie H et al. Modulation by prostaglandin D2 of glucagon and insulin secretion in the perfused rat pancreas. 1983 Prostaglandins Leukot Med pmid:6361782
Norman PS The John Sheldon memorial lecture. Review of nasal therapy: update. 1983 J. Allergy Clin. Immunol. pmid:6195204
Feinstein MB et al. The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin). 1983 Biochem. Biophys. Res. Commun. pmid:6307295
Watanabe Y et al. Localization of prostaglandin D2 binding protein and NADP-linked 15-hydroxyprostaglandin D2 dehydrogenase in the Purkinje cells of miniature pig cerebellum. 1983 Proc. Natl. Acad. Sci. U.S.A. pmid:6308629
Bregman MD and Meyskens FL In vitro modulation of human and murine melanoma growth by prostanoid analogues. 1983 Prostaglandins pmid:6581509
Gaetani P et al. [Prostaglandin D2 in subarachnoid hemorrhage. Biological and diagnostic implications]. 1983 Jul-Aug Riv Patol Nerv Ment pmid:6598516
Brus R et al. Effect of prostaglandins on morphine-induced catalepsy in mice. 1983 Sep-Dec Acta Physiol Pol pmid:6679984
Bito LZ Comparison of the ocular hypotensive efficacy of eicosanoids and related compounds. 1984 Exp. Eye Res. pmid:6370708
Barrow SE et al. Measurement of prostaglandin D2 and identification of metabolites in human plasma during intravenous infusion. 1984 Prostaglandins pmid:6441188
Bertelé V et al. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products. 1984 Blood pmid:6426554
Vicenzi E et al. Human mononuclear phagocytes from different anatomical sites differ in their capacity to metabolize arachidonic acid. 1984 Clin. Exp. Immunol. pmid:6432383
Nishi S et al. Different effects of prostaglandin E1, E2 and D2 on pancreatic somatostatin release. 1984 Horm. Metab. Res. pmid:6152434
Neely SM et al. Mechanism and characteristics of platelet activation by haematin. 1984 Br. J. Haematol. pmid:6383458
Uchizono K [Studies of sleep inducing substance]. 1984 Nippon Rinsho pmid:6384575
Philips JB and Lyrene RK Prostaglandins, related compounds, and the perinatal pulmonary circulation. 1984 Clin Perinatol pmid:6386270
Rao PS et al. Prostaglandin D2 in canine endotoxic shock. Hemodynamic, hematologic, biochemical, and blood gas analyses. 1984 Am. J. Obstet. Gynecol. pmid:6424477
Schick B et al. Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease. 1984 J. Immunol. pmid:6425408
Dembinska-Kieć A et al. Formation of leukotriene C4-like material by rat brain tissue. 1984 Eur. J. Pharmacol. pmid:6426980
Kawamura M and Koshihara Y Prostaglandin D2 lowers nuclear DNA polymerase activity in cultured mastocytoma cells. 1984 Prostaglandins pmid:6427850
Vincent JE et al. The effect of 5-(2-chlorobenzyl)-5,6,7,7a-tetrahydro 4H-thieno (3.2-C)-pyridine-2-one hydrochloride (PCR 3787), a metabolite of ticlopidine, on the aggregation of human platelets in vitro and on the aggregation inhibiting action of PGI2 and PGD2. 1984 Prostaglandins Leukot Med pmid:6396655
Weichman BM et al. SK&F 88046: a unique pharmacologic antagonist of bronchoconstriction induced by leukotriene D4, thromboxane and prostaglandins F2 alpha and D2 in vitro. 1984 J. Pharmacol. Exp. Ther. pmid:6582266
Higashida H et al. Facilitation of synaptic transmission by prostaglandin D2 at synapses between NG108-15 hybrid and muscle cells. 1984 Brain Res. pmid:6324947
Bertelé V et al. SQ 22536, an adenylate-cyclase inhibitor, prevents the antiplatelet effect of dazoxiben, a thromboxane-synthetase inhibitor. 1984 Thromb. Haemost. pmid:6326343
Chapnick BM Divergent influences of leukotrienes C4, D4, and E4 on mesenteric and renal blood flow. 1984 Am. J. Physiol. pmid:6326595
Gardiner PJ and Browne JL Tussive activity of inhaled PGD2 in the cat and characterisation of the receptor(s) involved. 1984 Prostaglandins Leukot Med pmid:6328541
Zavoico GB and Feinstein MB Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase. 1984 Biochem. Biophys. Res. Commun. pmid:6329175
Pan IQ et al. Alteration of platelet responses to metabolites of arachidonic acid by oral contraceptives. 1984 Br. J. Haematol. pmid:6089860
Nilsson J and Olsson AG Prostaglandin E1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. 1984 Atherosclerosis pmid:6093830
Mitsuma T and Nogimori T Effects of substance P, angiotensin II, oxotremorine and prostaglandin D2 on thyrotropin secretion in rats. 1984 Horm. Res. pmid:6201427
Ennis M et al. Prostaglandin and histamine release from stimulated rat peritoneal mast cells. 1984 Agents Actions pmid:6203356
Seregi A et al. Decreased levels of brain cyclo-oxygenase products as a possible cause of increased seizure susceptibility in convulsion-prone gerbils. 1984 Brain Res. pmid:6430471
Ikai K et al. Prostaglandin D2 and prostaglandin D synthetase in mast cell deficient mice. 1984 Prostaglandins pmid:6435183
Holgate ST and Robinson C 6,9-deepoxy-6,9-(phenylimino)-delta 6,8-Prostaglandin I1, (U-60,257) stimulates prostaglandin D2 and inhibits thromboxane B2 release from ionophore challenged human dispersed lung cells. 1984 Br. J. Pharmacol. pmid:6439267
Erman A and Nasjletti A Enhancement of renal medulla prostaglandin synthetase activity by dexamethasone treatment in the rat. 1984 Biochem. Biophys. Res. Commun. pmid:6428405
Inoué S et al. Differential sleep-promoting effects of five sleep substances nocturnally infused in unrestrained rats. 1984 Proc. Natl. Acad. Sci. U.S.A. pmid:6592612
Inoué S et al. Little sleep-promoting effect of three sleep substances diurnally infused in unrestrained rats. 1984 Neurosci. Lett. pmid:6593603
Peters SP et al. Effect of prostaglandin D2 in modulating histamine release from human basophils. 1984 J. Pharmacol. Exp. Ther. pmid:6198512
Marsden KA et al. The effect of prostaglandin D2 (PGD2) on circulating eosinophils. 1984 Prostaglandins Leukot Med pmid:6593748
Uemura S et al. Inotropic effects of prostaglandin D2 and E1 on the newborn rabbit heart. 1984 Pediatr. Res. pmid:6596550
Heavey DJ et al. Effects of intravenous infusions of prostaglandin D2 in man. 1984 Prostaglandins pmid:6596653
Mahmud I et al. On the identification and biological properties of prostaglandin J2. 1984 Prostaglandins Leukot Med pmid:6597446
Arisawa M et al. Direct suppressive effect of prostaglandin D2 on growth hormone secretion from rat anterior pituitary. 1984 Asia Oceania J Obstet Gynaecol pmid:6598030
Kikawa Y et al. 9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. 1984 Proc. Natl. Acad. Sci. U.S.A. pmid:6584883
Sakai T et al. Prostaglandin D2 inhibits the proliferation of human malignant tumor cells. 1984 Prostaglandins pmid:6584941
Imashuku S et al. [Differentiation induction and potentiation of chemotherapy by PGE1 infusion in patients with neuroblastoma--effect of PGE1 on metastatic potential of neuroblastoma]. 1984 Gan To Kagaku Ryoho pmid:6585182
Nakajima M and Toda N Neuroeffector actions of prostaglandin D2 on isolated dog mesenteric arteries. 1984 Prostaglandins pmid:6587438
Andersen NH and Hartzell CJ High-field 1H NMR studies of prostaglandin H2 and its decomposition pathways. 1984 Biochem. Biophys. Res. Commun. pmid:6587849
Gal D et al. Effect of radiation on prostaglandin production by human bowel in vitro. 1984 Int. J. Radiat. Oncol. Biol. Phys. pmid:6588048